Dabur India Limited · NSE:DABUR

Dabur India — CLSA, UBS & IDFC Investor Conferences - November 2015

33 slides from Dabur India's conference presentation, November 2015

  1. Slide 1: Dabur India Ltd Investor Presentation

    Dabur India Ltd Investor Presentation November 2015 1

  2. Slide 2: Dabur Overview

    Dabur Overview Overview Accolades D b Gastrina Dabur G t i wins i One of the oldest and largest Silver at Cannes 2015 FMCG Companies in the country Dedicated to the Health and Well‐ Being of every household World’s largest in Ayurveda and Dabur ranked amongst t l healthcare natural h lth IIndia's di

  3. Slide 3: Key Milestones

    Keyy Milestones • Established by Dr SK Burman in Kolkata 1884 • Came out with first public issue 1994 • Inducted professional management 1998 • Crossed the INR 10 billion turnover mark 2000 • Acquired Balsara which had oral & home care 2005 portfolio p • Acquired the skin care company ‐ Fem Pharma 2

  4. Slide 4: Global Business Footprint

    Global Business Footprint p 4

  5. Slide 5: Domestic Distribution Structure

    Domestic Distribution Structure 5

  6. Slide 6: Performance Snapshot

    Performance Snapshot p Sales Market Cap p in INR bn 78.1 in INR bn 70.7 466.5 61.5 61 5 52.8 40.8 313.1 238.9 167.2 185 185.4 4 FY11 FY12 FY13 FY14 FY15 Profit After Tax FY11 FY12 FY13 FY14 FY15 in INR bn 10 7 10.7 9.1 7.6 Robust profitable growth translating 5.7 6.4 into superior shareholder return

  7. Slide 7: Strong Financial Profile

    Strongg Financial Profile ROIC Net Worth (INR Bn) 45.2% 43.6% 33 5 33.5 38 3% 38.3% 32.7% 34.0% 26.6 21.0 17.2 13.9 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 *EBITDA EBITDA Margin EPS (Rs.) (Rs ) 61 6.1 20.4% 5.2 4.4 18.9% 3.7 17.9% 17.8% 18.2% 3.3 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY1

  8. Slide 8: Business Structure

    Business Structure Domestic FMCG (66%) Domestic (69%) Others (3%) Dabur India Organic Ltd Ltd. International i l (22%) International i l Namaste Labs (6%) (31%) Hobi Group (3%) * Others include Retail, Commodity exports etc Note: % figure in brackets indicate % share in Consolidated Sales for FY15 8

  9. Slide 9: Sales By Business Vertical

    Sales Byy Business Vertical Domestic FMCG Business FY15 Healthcare Healthcare HPC Foods Health (33%) Supplements Foods 18% Domestic 19% Digestives Di ti Skin Care Ski HPC(48%) 6% FMCG* 5% Oral Care OTC & 14% Ethicals Hair Care 9% Foods(19%) 23% Home Care 6% International Sales FY15 Europe Internatio

  10. Slide 10: Continue to build bigger brands

    Continue to build bigger gg brands 10bn+ 1bn+ 14 brands with turnover of INR 1bn+ with 3 brands over 10bn 10

  11. Slide 11: Competitive Position

    Competitive p Position We continue to lead across verticals ‐ Healthcare , HPC and Foods #Relative Competitive Position #1 #1 #2 #2 #2 #1 #1 #2 #3 #1 #1 Honey Chyawanprash Baby Massage Glucose Hair Oils Air Freshners Skin Care‐ Toilet Oral Care Mosquito Juices Oil Bleaches Cleaners Repellant Creams

  12. Slide 12: Domestic Growth Strategy

    Domestic Growth Strategy gy Continued Focus on Innovation Buildingg Consumer Connect Distribution Expansion Focus on Health and well being 12

  13. Slide 13: Continued Focus on Innovation

    Continued Focus on Innovation 13

  14. Slide 14: Recently Launched

    Recentlyy Launched India Dabur Almond Oxy Prowhite Facial Oxy Crème+Crème Vatika Jasmine Hair Shampoo Kits Bleach‐ Salon Pack Oil International Dermoviva Face Care Range‐ Facewash Vatika Cactus & Coconut & Scrub Hair Mask Dermoviva Sun Lotion 14

  15. Slide 15: Product Evolution

    Product Evolution Chyawanprash Red Toothpowder Hajmola Amla Hair Oil 15

  16. Slide 16: Building Consumer Connect

    Building ld Consumer Connect 16

  17. Slide 17: Key Activations

    Keyy Activations •Initiated the association with ‘Sulabh’ in our endeavour to join hands with India’s Sanifresh: Swachh ‘Swachh Bharat Mission’ Bharat Initiative Thi initiative •This i i i i was designed d i d to help h l educate d h need consumers on the d to use toilets il to maintain health and h

  18. Slide 18: Increasing Doctor Advocacy

    Increasingg Doctor Advocacyy Project LEAD: Leveraging Through Empowered Anchoring & Detailing • Front end teams to be separated for Healthcare (OTC & Doctor Advocacy is the key to Ethicals) and the rest of the Domestic FMCG business to enhance consumer franchise have focused attention on both segmen

  19. Slide 19: Distribution Expansion

    Di ib i EExpansion Distribution i 19

  20. Slide 20: Enhancing Distribution Reach

    Enhancingg Distribution Reach • Rolled out in FY13 to expand direct coverage in rural markets • Direct Village coverage has increased from 14000 villages in FY11 Project Double to 44,000 villages in FY15 • We plan to increase the coverage to 50,000 50 000 villages in FY16 and 60,000 in FY17 • Aimed

  21. Slide 21: Focus on Health and Well being

    Focus on Health and Well being 21

  22. Slide 22: Health and Well-Being

    Health and Well‐Beingg Health & Well being ‐ The underlying theme across the portfolio Dabur Baby Massage Oil Focus on Ayurvedic Innovations in Dabur Honeyy OTC‐ OTC No.1 No 1 in Women Healthcare Free of paraffin and Weight Management parabens Health Tonics Category 22

  23. Slide 23: Health and Well-Being

    Health and well‐ Beingg Health & Well Being focus has been extended to HPC and Foods Red Tooth Paste‐ Focus on Ingredient Effectiveness Recently introduced the ‘Real Wellnezz” range with the Jamun flavour Odomos Protection from Dengue Sanifresh‐ Toilet Cleaner Activ g To safeguard the health of the

  24. Slide 24: International Business Overview

    International Business Overview In INR Mn 23108 24226 Key Markets Middle South Africa 18338 East Asia 16161 8992 Key Categories Hair Skin Oral Care Care Care FY11 FY12 FY13 FY14 FY15 International Sales FY15 •Comprises 31% of Consolidated Sales in FY15 Europe Middle •Localized supply chain network f

  25. Slide 25: International Competitive Position

    International‐ Competitive p Position 44.1% 36 5% 36.5% 36.6% No.1 Position in the Hair Cream Hair Creams* Category in KSA, UAE and Egypt KSA UAE Egypt 64.8% 67.3% 27 5% 27.5% N 1 Position No.1 P iti in i the th Hair H i Oils Oil Hair Oils* Category in KSA & Egypt and No.2 in UAE KSA UAE Egypt *Volu

  26. Slide 26: Overseas Markets Strategy

    Overseas Markets Strategy gy • Increase penetration in Hair Care Middle East • Strengthen Oral Care and Skin Care • Increase share of Hair Care byy scalingg up p ORS Africa (Namaste portfolio) • Cross pollinate with products from MENA • Increase product d width d h and d penetration in Asia neighbou

  27. Slide 27: Financial Highlights Q2FY16

    Financial Highlights g g Q2FY16 Growth 8.7% 17.8% 18.7% Sales EBITDA PAT Rs. 2092.1 crs Rs. 459.2 crs Rs. 341.1 crs 27

  28. Slide 28: Margin Profile Q2FY16

    Margin g Profile Q2FY16 16.3% 55.0% 21.9% 14.9% 53 0% 53.0% 20.3% Q2FY15 Q2FY16 Q2FY15 Q2FY16 Q2FY15 Q2FY16 Gross Margin EBITDA Margin PAT Margin 193bps 170bps 136bps 28

  29. Slide 29: Sustainability: A Key Focus

    Sustainability: y A Keyy Focus Dabur is committed to being a responsible company and making a positive contribution to Society and Environment 1,141 acres under 2,028 beneficiary 9,13,750 school kids cultivation for rare families of our Self – Help benefitting from our medicinal herbs in India Group

  30. Slide 30: Shareholding, Price & Dividends

    Shareholding, g Price & Dividends Share Holding Pattern As on 30th Sep 2015 Dabur Share Price Trend Others 6.3% DII 4.7% FII 20.8% Promoters 68.1% Dividend History 250% 250% 200% 200% 200% 175% 175% 175% 140% 150% 150% 115% 130% FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 *Bonus

  31. Slide 31: Consolidated P&L

    Consolidated P&L DIL (Consolidated) P&L in Rs. million Q2FY16 Q2FY15 YoY (%) H1 FY16 H1 FY15 YoY (%) Net Sales 20,921 19,241 8.7% 41,562 37,880 9.7% Other Operating p g Income 41 55 95 104 Material Cost 9,418 9,034 4.3% 18,976 18,260 3.9% % of Sales 45.0% 47.0% 45.7% 48.2% Employee Costs 2,008 1,825

  32. Slide 32: Statement of Assets and Liabilities

    Statement of Assets and Liabilities in Rs. million As at 31/03/2015) As at 31/03/2014) Â EQUITY AND LIABILITIES 1 Shareholders’ funds (a) Share capital 1756.5 1743.8 (b) Reserves and surplus 31784.99 31784 24815.88 24815 Sub-total - Shareholders' funds 33541.4 26559.6 2. Minority interest 181.6 159.

  33. Slide 33: Thank You

    Th k YYou Thank 33

Dabur India — CLSA, UBS & IDFC Investor Conferences - November 2015 on 6ix